PDE5A and cardiac hypertrophy: Additionally, sildenafil attenuates TAC-induced cardiac hypertrophy and ameliorates T-tubule remodeling, suggesting another potential mechanism underlying the therapeutic benefits of PDE5 inhibitors in cardiac hypertrophy (310).